The DOI matches its Crossref record; 95 of the 95 references it cites were found in a registry or an index.
Human dendritic cells in cancer
Abstract
Dendritic cells (DCs) are professional antigen-presenting cells, orchestrating innate and adaptive immunity during infections, autoimmune diseases, and malignancies. Since the discovery of DCs almost 50 years ago, our understanding of their biology in humans has increased substantially. Here, we review both antitumor and tolerogenic DC responses in cancer and discuss lineage-specific contributions by their functionally specialized subsets, including the conventional DC (cDC) subsets cDC1 and cDC2, the newly described DC3, and the plasmacytoid DCs (pDCs), focusing on the human setting. In addition, we review the lineage-unrestricted “mature DCs enriched in immunoregulatory molecules” (mregDC) state recently described across different human tumors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dendritic cells in cancer immunology and immunotherapy
Wculek, S. K., Cueto, F. J., Mujal, A. M., Melero, I., Krummel, M. F., & Sancho, D. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-019-0210-z · Cited by 2,574
IDENTIFICATION OF A NOVEL CELL TYPE IN PERIPHERAL LYMPHOID ORGANS OF MICE
Steinman, R. M., & Cohn, Z. A. (1973) · The Journal of Experimental Medicine · doi:10.1084/jem.137.5.1142 · Cited by 2,424
Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors
Villani, A.-C., Satija, R., Reynolds, G., Sarkizova, S., Shekhar, K., Fletcher, J., Griesbeck, M., Butler, A., Zheng, S., Lazo, S., et al. (2017) · Science · doi:10.1126/science.aah4573 · Cited by 2,413
Böttcher, J. P., Bonavita, E., Chakravarty, P., Blees, H., Cabeza-Cabrerizo, M., Sammicheli, S., Rogers, N. C., Sahai, E., Zelenay, S., & Reis e Sousa, C. (2018) · Cell · doi:10.1016/j.cell.2018.01.004 · Cited by 1,857
Dendritic cells, monocytes and macrophages: a unified nomenclature based on ontogeny
Guilliams, M., Ginhoux, F., Jakubzick, C., Naik, S. H., Onai, N., Schraml, B. U., Segura, E., Tussiwand, R., & Yona, S. (2014) · Nature Reviews Immunology · doi:10.1038/nri3712 · Cited by 1,819
Self-citationLandscape and Dynamics of Single Immune Cells in Hepatocellular Carcinoma
Zhang, Q., He, Y., Luo, N., Patel, S. J., Han, Y., Gao, R., Modak, M., Carotta, S., Haslinger, C., Kind, D., et al. (2019) · Cell · doi:10.1016/j.cell.2019.10.003 · Cited by 1,624
A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells
Cheng, S., Li, Z., Gao, R., Xing, B., Gao, Y., Yang, Y., Qin, S., Zhang, L., Ouyang, H., Du, P., et al. (2021) · Cell · doi:10.1016/j.cell.2021.01.010 · Cited by 1,601
Single-Cell Analyses Inform Mechanisms of Myeloid-Targeted Therapies in Colon Cancer
Zhang, L., Li, Z., Skrzypczynska, K. M., Fang, Q., Zhang, W., O’Brien, S. A., He, Y., Wang, L., Zhang, Q., Kim, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.03.048 · Cited by 1,526
Zilionis, R., Engblom, C., Pfirschke, C., Savova, V., Zemmour, D., Saatcioglu, H. D., Krishnan, I., Maroni, G., Meyerovitz, C. V., Kerwin, C. M., et al. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.009 · Cited by 1,475
Spranger, S., Dai, D., Horton, B., & Gajewski, T. F. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.04.003 · Cited by 1,441 · cited 2×
“Previous animal model studies have also shown that intratumor CD103+ DCs are necessary for CD8+ effector T cell recruitment (25).”
BackgroundResultHuman dendritic cell subsets: an update
Collin, M., & Bigley, V. (2018) · Immunology · doi:10.1111/imm.12888 · Cited by 1,301
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses
Lavin, Y., Kobayashi, S., Leader, A., Amir, E.-A. D., Elefant, N., Bigenwald, C., Remark, R., Sweeney, R., Becker, C. D., Levine, J. H., et al. (2017) · Cell · doi:10.1016/j.cell.2017.04.014 · Cited by 1,209
Broz, M. L., Binnewies, M., Boldajipour, B., Nelson, A. E., Pollack, J. L., Erle, D. J., Barczak, A., Rosenblum, M. D., Daud, A., Barber, D. L., et al. (2014) · Cancer Cell · doi:10.1016/j.ccell.2014.09.007 · Cited by 1,207
Salmon, H., Idoyaga, J., Rahman, A., Leboeuf, M., Remark, R., Jordan, S., Casanova-Acebes, M., Khudoynazarova, M., Agudo, J., Tung, N., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.03.012 · Cited by 1,201
Self-citationDieu-Nosjean, M.-C., Antoine, M., Danel, C., Heudes, D., Wislez, M., Poulot, V., Rabbe, N., Laurans, L., Tartour, E., de Chaisemartin, L., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.0284 · Cited by 1,031
Roberts, E. W., Broz, M. L., Binnewies, M., Headley, M. B., Nelson, A. E., Wolf, D. M., Kaisho, T., Bogunovic, D., Bhardwaj, N., & Krummel, M. F. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.06.003 · Cited by 1,026
A natural killer–dendritic cell axis defines checkpoint therapy–responsive tumor microenvironments
Barry, K. C., Hsu, J., Broz, M. L., Cueto, F. J., Binnewies, M., Combes, A. J., Nelson, A. E., Loo, K., Kumar, R., Rosenblum, M. D., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0085-8 · Cited by 1,021
Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab), Savas, P., Virassamy, B., Ye, C., Salim, A., Mintoff, C. P., Caramia, F., Salgado, R., Byrne, D. J., Teo, Z. L., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0078-7 · Cited by 992
A conserved dendritic-cell regulatory program limits antitumour immunity
Maier, B., Leader, A. M., Chen, S. T., Tung, N., Chang, C., LeBerichel, J., Chudnovskiy, A., Maskey, S., Walker, L., Finnigan, J. P., et al. (2020) · Nature · doi:10.1038/s41586-020-2134-y · Cited by 941
Germain, C., Gnjatic, S., Tamzalit, F., Knockaert, S., Remark, R., Goc, J., Lepelley, A., Becht, E., Katsahian, S., Bizouard, G., et al. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201309-1611oc · Cited by 833
Interleukins in cancer: from biology to therapy
Briukhovetska, D., Dörr, J., Endres, S., Libby, P., Dinarello, C. A., & Kobold, S. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-021-00363-z · Cited by 781
Cross-tissue single-cell landscape of human monocytes and macrophages in health and disease
Mulder, K., Patel, A. A., Kong, W. T., Piot, C., Halitzki, E., Dunsmore, G., Khalilnezhad, S., Irac, S. E., Dubuisson, A., Chevrier, M., et al. (2021) · Immunity · doi:10.1016/j.immuni.2021.07.007 · Cited by 678
Self-citationHuman Inflammatory Dendritic Cells Induce Th17 Cell Differentiation
Segura, E., Touzot, M., Bohineust, A., Cappuccio, A., Chiocchia, G., Hosmalin, A., Dalod, M., Soumelis, V., & Amigorena, S. (2013) · Immunity · doi:10.1016/j.immuni.2012.10.018 · Cited by 676
Unleashing Type-2 Dendritic Cells to Drive Protective Antitumor CD4+ T Cell Immunity
Binnewies, M., Mujal, A. M., Pollack, J. L., Combes, A. J., Hardison, E. A., Barry, K. C., Tsui, J., Ruhland, M. K., Kersten, K., Abushawish, M. A., et al. (2019) · Cell · doi:10.1016/j.cell.2019.02.005 · Cited by 629
cDC1 prime and are licensed by CD4(+) T cells to induce anti-tumour immunity
Ferris, S. T., Durai, V., Wu, R., Theisen, D. J., Ward, J. P., Bern, M. D., Davidson, J. T., Bagadia, P., Liu, T., Briseño, C. G., et al. (2020) · Nature · doi:10.1038/s41586-020-2611-3 · Cited by 611
The Role of Type 1 Conventional Dendritic Cells in Cancer Immunity
Böttcher, J. P., & Reis e Sousa, C. (2018) · Trends in Cancer · doi:10.1016/j.trecan.2018.09.001 · Cited by 607
Transcriptional Basis of Mouse and Human Dendritic Cell Heterogeneity
Brown, C. C., Gudjonson, H., Pritykin, Y., Deep, D., Lavallée, V.-P., Mendoza, A., Fromme, R., Mazutis, L., Ariyan, C., Leslie, C., et al. (2019) · Cell · doi:10.1016/j.cell.2019.09.035 · Cited by 601
Mapping the human DC lineage through the integration of high-dimensional techniques
See, P., Dutertre, C.-A., Chen, J., Günther, P., McGovern, N., Irac, S. E., Gunawan, M., Beyer, M., Händler, K., Duan, K., et al. (2017) · Science · doi:10.1126/science.aag3009 · Cited by 574
Self-citationAllen, C. E., Merad, M., & McClain, K. L. (2018) · New England Journal of Medicine · doi:10.1056/nejmra1607548 · Cited by 570
Dutertre, C.-A., Becht, E., Irac, S. E., Khalilnezhad, A., Narang, V., Khalilnezhad, S., Ng, P. Y., van den Hoogen, L. L., Leong, J. Y., Lee, B., et al. (2019) · Immunity · doi:10.1016/j.immuni.2019.08.008 · Cited by 520
Self-citationChen, Y.-P., Yin, J.-H., Li, W.-F., Li, H.-J., Chen, D.-P., Zhang, C.-J., Lv, J.-W., Wang, Y.-Q., Li, X.-M., Li, J.-Y., et al. (2020) · Cell Research · doi:10.1038/s41422-020-0374-x · Cited by 463
Dendritic Cell Infiltration and Prognosis of Early Stage Breast Cancer
Treilleux, I., Blay, J.-Y., Bendriss-Vermare, N., Ray-Coquard, I., Bachelot, T., Guastalla, J.-P., Bremond, A., Goddard, S., Pin, J.-J., Barthelemy-Dubois, C., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0684 · Cited by 460
TIM-3 regulates CD103+ dendritic cell function and response to chemotherapy in breast cancer
de Mingo Pulido, Á., Gardner, A., Hiebler, S., Soliman, H., Rugo, H. S., Krummel, M. F., Coussens, L. M., & Ruffell, B. (2018) · Cancer Cell · doi:10.1016/j.ccell.2017.11.019 · Cited by 388
TIM-3 restrains anti-tumour immunity by regulating inflammasome activation
Dixon, K. O., Tabaka, M., Schramm, M. A., Xiao, S., Tang, R., Dionne, D., Anderson, A. C., Rozenblatt-Rosen, O., Regev, A., & Kuchroo, V. K. (2021) · Nature · doi:10.1038/s41586-021-03626-9 · Cited by 372
Bourdely, P., Anselmi, G., Vaivode, K., Ramos, R. N., Missolo-Koussou, Y., Hidalgo, S., Tosselo, J., Nuñez, N., Richer, W., Vincent-Salomon, A., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.06.002 · Cited by 357
Sisirak, V., Faget, J., Gobert, M., Goutagny, N., Vey, N., Treilleux, I., Renaudineau, S., Poyet, G., Labidi-Galy, S. I., Goddard-Leon, S., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3468 · Cited by 345
Hartmann, E., Wollenberg, B., Rothenfußer, S., Wagner, M., Wellisch, D., Mack, B., Giese, T., Gires, O., Endres, S., & Hartmann, G. (2003) · PubMed · Cited by 332
Cortez, V. S., Ulland, T. K., Cervantes-Barragan, L., Bando, J. K., Robinette, M. L., Wang, Q., White, A. J., Gilfillan, S., Cella, M., & Colonna, M. (2017) · Nature Immunology · doi:10.1038/ni.3809 · Cited by 332
Nizzoli, G., Krietsch, J., Weick, A., Steinfelder, S., Facciotti, F., Gruarin, P., Bianco, A., Steckel, B., Moro, M., Crosti, M., et al. (2013) · Blood · doi:10.1182/blood-2013-04-495424 · Cited by 330
Conrad, C., Gregorio, J., Wang, Y.-H., Ito, T., Meller, S., Hanabuchi, S., Anderson, S., Atkinson, N., Ramirez, P. T., Liu, Y.-J., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-2271 · Cited by 314
Genetic models of human and mouse dendritic cell development and function
Anderson, D. A., Dutertre, C.-A., Ginhoux, F., & Murphy, K. M. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-020-00413-x · Cited by 313
Self-citationDistinct progenitor lineages contribute to the heterogeneity of plasmacytoid dendritic cells
Rodrigues, P. F., Alberti-Servera, L., Eremin, A., Grajales-Reyes, G. E., Ivanek, R., & Tussiwand, R. (2018) · Nature Immunology · doi:10.1038/s41590-018-0136-9 · Cited by 301
Jensen, T. O., Schmidt, H., Møller, H. J., Donskov, F., Høyer, M., Sjoegren, P., Christensen, I. J., & Steiniche, T. (2012) · Cancer · doi:10.1002/cncr.26511 · Cited by 281
Laoui, D., Keirsse, J., Morias, Y., Van Overmeire, E., Geeraerts, X., Elkrim, Y., Kiss, M., Bolli, E., Lahmar, Q., Sichien, D., et al. (2016) · Nature Communications · doi:10.1038/ncomms13720 · Cited by 277
de Mingo Pulido, Á., Hänggi, K., Celias, D. P., Gardner, A., Li, J., Batista-Bittencourt, B., Mohamed, E., Trillo-Tinoco, J., Osunmakinde, O., Peña, R., et al. (2021) · Immunity · doi:10.1016/j.immuni.2021.04.019 · Cited by 270
Dendritic cells in cancer immunology
Murphy, T. L., & Murphy, K. M. (2022) · Cellular & Molecular Immunology · doi:10.1038/s41423-021-00741-5 · Cited by 269
Tumor-infiltrating dendritic cell states are conserved across solid human cancers
Gerhard, G. M., Bill, R., Messemaker, M., Klein, A. M., & Pittet, M. J. (2021) · Journal of Experimental Medicine · doi:10.1084/jem.20200264 · Cited by 247
Dress, R. J., Dutertre, C.-A., Giladi, A., Schlitzer, A., Low, I., Shadan, N. B., Tay, A., Lum, J., Kairi, M. F. B. M., Hwang, Y. Y., et al. (2019) · Nature Immunology · doi:10.1038/s41590-019-0420-3 · Cited by 245
Self-citationCytlak, U., Resteu, A., Pagan, S., Green, K., Milne, P., Maisuria, S., McDonald, D., Hulme, G., Filby, A., Carpenter, B., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.07.003 · Cited by 244
Mittag, D., Proietto, A. I., Loudovaris, T., Mannering, S. I., Vremec, D., Shortman, K., Wu, L., & Harrison, L. C. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002632 · Cited by 243
Labidi-Galy, S. I., Sisirak, V., Meeus, P., Gobert, M., Treilleux, I., Bajard, A., Combes, J.-D., Faget, J., Mithieux, F., Cassignol, A., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0367 · Cited by 239
Incidence of Langerhans cell histiocytosis in children: A population‐based study
Stålemark, H., Laurencikas, E., Karis, J., Gavhed, D., Fadeel, B., & Henter, J. (2008) · Pediatric Blood & Cancer · doi:10.1002/pbc.21504 · Cited by 225
Adjustment of dendritic cells to the breast-cancer microenvironment is subset specific
Michea, P., Noël, F., Zakine, E., Czerwinska, U., Sirven, P., Abouzid, O., Goudot, C., Scholer-Dahirel, A., Vincent-Salomon, A., Reyal, F., et al. (2018) · Nature Immunology · doi:10.1038/s41590-018-0145-8 · Cited by 223
Faget, J., Bendriss-Vermare, N., Gobert, M., Durand, I., Olive, D., Biota, C., Bachelot, T., Treilleux, I., Goddard-Leon, S., Lavergne, E., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-2409 · Cited by 217
Meyer, M. A., Baer, J. M., Knolhoff, B. L., Nywening, T. M., Panni, R. Z., Su, X., Weilbaecher, K. N., Hawkins, W. G., Ma, C., Fields, R. C., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03600-6 · Cited by 217
Aspord, C., Leccia, M.-T., Charles, J., & Plumas, J. (2013) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-13-0114-t · Cited by 187
IFNγ-Dependent Tissue-Immune Homeostasis Is Co-opted in the Tumor Microenvironment
Nirschl, C. J., Suárez-Fariñas, M., Izar, B., Prakadan, S., Dannenfelser, R., Tirosh, I., Liu, Y., Zhu, Q., Devi, K. S. P., Carroll, S. L., et al. (2017) · Cell · doi:10.1016/j.cell.2017.06.016 · Cited by 182
Plasmacytoid dendritic cell in immunity and cancer
Mitchell, D., Chintala, S., & Dey, M. (2018) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2018.06.012 · Cited by 178
Nakamizo, S., Dutertre, C.-A., Khalilnezhad, A., Zhang, X. M., Lim, S., Lum, J., Koh, G., Foong, C., Yong, P. J. A., Tan, K. J., et al. (2021) · Journal of Experimental Medicine · doi:10.1084/jem.20202345 · Cited by 171
Self-citationMyeloid malignancies and the microenvironment
Korn, C., & Méndez-Ferrer, S. (2017) · Blood · doi:10.1182/blood-2016-09-670224 · Cited by 169
CD103 and Intratumoral Immune Response in Breast Cancer
Wang, Z., Milne, K., Derocher, H., Webb, J. R., Nelson, B. H., & Watson, P. H. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0732 · Cited by 169
Plasmacytoid dendritic cells infiltrating ovarian cancer are associated with poor prognosis
Labidi‐Galy, S. I., Treilleux, I., Goddard‐Léon, S., Combes, J., Blay, J., Ray-Coquard, I. L., Caux, C., & Bendriss‐Vermare, N. (2012) · OncoImmunology · doi:10.4161/onci.18801 · Cited by 162
Smalley, I., Chen, Z., Phadke, M., Li, J., Yu, X., Wyatt, C., Evernden, B., Messina, J. L., Sarnaik, A., Sondak, V. K., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-1694 · Cited by 161
Major alterations in the mononuclear phagocyte landscape associated with COVID-19 severity
Kvedaraite, E., Hertwig, L., Sinha, I., Ponzetta, A., Myrberg, I. H., Lourda, M., Dzidic, M., Akber, M., Klingström, J., Folkesson, E., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2018587118 · Cited by 139
Self-citationSecreted gelsolin inhibits DNGR-1-dependent cross-presentation and cancer immunity
Giampazolias, E., Schulz, O., Lim, K. H. J., Rogers, N. C., Chakravarty, P., Srinivasan, N., Gordon, O., Cardoso, A., Buck, M. D., Poirier, E. Z., et al. (2021) · Cell · doi:10.1016/j.cell.2021.05.021 · Cited by 139
Sisirak, V., Vey, N., Goutagny, N., Renaudineau, S., Malfroy, M., Thys, S., Treilleux, I., Labidi‐Galy, S. I., Bachelot, T., Dezutter‐Dambuyant, C., et al. (2013) · International Journal of Cancer · doi:10.1002/ijc.28072 · Cited by 124
Bakdash, G., Buschow, S. I., Gorris, M. A. J., Halilović, A., Hato, S. V., Sköld, A. E., Schreibelt, G., Sittig, S. P., Torensma, R., Boer, T. D., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-1695 · Cited by 123
Ex vivo pulsed dendritic cell vaccination against cancer
Gu, Y., Zhao, X., & Song, X. (2020) · Acta Pharmacologica Sinica · doi:10.1038/s41401-020-0415-5 · Cited by 116
Expanding dendritic cell nomenclature in the single-cell era
Ginhoux, F., Guilliams, M., & Mérad, M. (2022) · Nature reviews. Immunology · doi:10.1038/s41577-022-00675-7 · Cited by 115
Self-citationPedroza‐González, A., Zhou, G., Vargas-Méndez, E., Boor, P. P. C., Mancham, S., Verhoef, C. K., Polak, W. G., Grünhagen, D. J., Pan, Q., Janssen, H. L. A., et al. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1008355 · Cited by 114
Movassagh, M., Spatz, A., Davoust, J. M., Lebecque, S., Romero, P. J., Pittet, M. J., Rimoldi, D., Liénard, D., Gugerli, O., Ferradini, L., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2969 · Cited by 114
Single-cell immunology: Past, present, and future
Ginhoux, F., Yalin, A., Dutertre, C., & Amit, I. (2022) · Immunity · doi:10.1016/j.immuni.2022.02.006 · Cited by 101
Self-citationSánchez-Paulete, A. R., Teijeira, Á., Quetglas, J. I., Rodriguez-Ruiz, M. E., Sánchez-Arráez, Á., Labiano, S., Etxeberría, I., Azpilikueta, A., Bolaños, E., Ballesteros-Briones, M. C., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-0933 · Cited by 91
Immunology of Plasmacytoid Dendritic Cells in Solid Tumors: A Brief Review
Koucký, V., Bouček, J., & Fialová, A. (2019) · Cancers · doi:10.3390/cancers11040470 · Cited by 76
Recent Advances in Experimental Dendritic Cell Vaccines for Cancer
Filin, I. Y., Kitaeva, K. V., Rutland, C. S., Rizvanov, A. A., & Solovyeva, V. V. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.730824 · Cited by 76
Caronni, N., Piperno, G. M., Simoncello, F., Romano, O., Vodret, S., Yanagihashi, Y., Dress, R. J., Dutertre, C., Bugatti, M., Bourdeley, P., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22535-z · Cited by 72
Self-citationElliott, B., Scolyer, R. A., Suciu, S., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0358 · Cited by 70
CD169 Defines Activated CD14+ Monocytes With Enhanced CD8+ T Cell Activation Capacity
Affandi, A. J., Olesek, K., Grabowska, J. A., Twilhaar, M. K. N., Rodríguez, E., Saris, A., Zwart, E. S., Nossent, E. J., Kalay, H., de Kok, M., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.697840 · Cited by 70
Roth, M. D., Gitlitz, B. J., Kiertscher, S. M., PARK, A. N., Mendenhall, M. A., Moldawer, N. P., & Figlin, R. A. (2000) · PubMed · Cited by 63
Tjomsland, V., Sandström, P., Spångéus, A., Messmer, D., Emilsson, J., Falkmer, S., Falkmer, S. E., Magnusson, K., Borch, K., & Larsson, M. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-87 · Cited by 59
Han, N., Zhang, Z., Liu, S., Ow, A., Ruan, M., Yang, W., & Zhang, C. (2017) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2017.02.012 · Cited by 58
Mastelic-Gavillet, B., Sarivalasis, A., Lozano, L. E., Wyss, T., Inogés, S., de Vries, I. J., Dartiguenave, F., Jichlinski, P., Derré, L., Coukos, G., et al. (2020) · European Journal of Cancer · doi:10.1016/j.ejca.2020.04.036 · Cited by 54
Cueto, F. J., del Fresno, C., Brandi, P., Combes, A. J., Hernández-García, E., Sánchez-Paulete, A. R., Enamorado, M., Bromley, C. P., Gómez, M. J., Conde‐Garrosa, R., et al. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-002054 · Cited by 49
Santegoets, S. J. A. M., Duurland, C. L., Jordanova, E. J., van Ham, V. J., Ehsan, I., Loof, N. M., Narang, V., Dutertre, C., Ginhoux, F., van Egmond, S. L., et al. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-001053 · Cited by 44
Self-citationDemoulin, S., Herfs, M. F., Somja, J., Roncarati, P., Delvenne, P., & Hubert, P. (2014) · International Journal of Cancer · doi:10.1002/ijc.29389 · Cited by 40
IL-10 in the microenvironment of HNSCC inhibits the CpG ODN induced IFN-α secretion of pDCs
Bruchhage, K., Heinrichs, S., Wollenberg, B., & Pries, R. (2018) · Oncology Letters · doi:10.3892/ol.2018.7772 · Cited by 40
Novel concepts in plasmacytoid dendritic cell (pDC) development and differentiation
Rodrigues, P. F., & Tussiwand, R. (2020) · Molecular Immunology · doi:10.1016/j.molimm.2020.07.006 · Cited by 35
Girard, M., Law, J. C., Edilova, M. I., & Watts, T. H. (2020) · Science Immunology · doi:10.1126/sciimmunol.abe0347 · Cited by 32
Human DC3 Antigen Presenting Dendritic Cells From Induced Pluripotent Stem Cells
Satoh, T., Toledo, M. A. S., Böhnke, J., Olschok, K., Flosdorf, N., Götz, K., Küstermann, C., Sontag, S., Seré, K., Koschmieder, S., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.667304 · Cited by 29
Gastric cancer patients have elevated plasmacytoid and CD1c+ dendritic cells in the peripheral blood
Liu, W., Zhao, J., Li, Q., Wang, Q., Zhou, Y. F., & Tong, Z. (2018) · Oncology Letters · doi:10.3892/ol.2018.7990 · Cited by 28
Shi, H., He, H., Cui, L., Kvedaraite, E., Bian, Z., Huang, T., Lee, C., Li, Z., He, J., Gong, Y., et al. (2021) · Blood · doi:10.1182/blood.2020009064 · Cited by 28
Self-citationLiu, J., Lu, G., Li, Z., Fuai, T., Liu, Y., & Cui, G. (2010) · Pathology - Research and Practice · doi:10.1016/j.prp.2010.03.011 · Cited by 19
Profiling dendritic cell subsets in head and neck squamous cell tonsillar cancer and benign tonsils
Abolhalaj, M., Askmyr, D., Sakellariou, C. A., Lundberg, K., Greiff, L., & Lindstedt, M. (2018) · Scientific Reports · doi:10.1038/s41598-018-26193-y · Cited by 19
Development of an Inflammatory CD14+ Dendritic Cell Subset in Humanized Mice
Iwabuchi, R., Ide, K., Terahara, K., Wagatsuma, R., Iwaki, R., Matsunaga, H., Tsunetsugu‐Yokota, Y., Takeyama, H., & Takahashi, Y. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.643040 · Cited by 11
Moutel, S., Beugnet, A., Schneider, A., Lombard, B., Loew, D., Amigorena, S., Perez, F., & Segura, É. (2020) · iScience · doi:10.1016/j.isci.2020.100987 · Cited by 10
Cited by
Immune checkpoint therapy for solid tumours: clinical dilemmas and future trends
Sun, Q., Hong, Z., Zhang, C., Wang, L., Han, Z., & Ma, D. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01522-4 · Cited by 598
Therapeutic cancer vaccines: Advancements, challenges, and prospects
Fan, T., Zhang, M., Yang, J., Zhu, Z., Cao, W., & Dong, C. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01674-3 · Cited by 597
Dendritic cells as shepherds of T cell immunity in cancer
Pittet, M. J., Di Pilato, M., Garris, C., & Mempel, T. R. (2023) · Immunity · doi:10.1016/j.immuni.2023.08.014 · Cited by 313
Zheng, X., Wang, X., Cheng, X., Liu, Z., Yin, Y., Li, X., Huang, Z., Wang, Z., Guo, W., Ginhoux, F., et al. (2023) · Nature Cancer · doi:10.1038/s43018-023-00599-8 · Cited by 172
Self-citationImmunobiology of primary sclerosing cholangitis
Cornillet, M., Geanon, D., Bergquist, A., & Björkström, N. K. (2025) · Hepatology · doi:10.1097/hep.0000000000001080 · Cited by 20
Metadata
- Authors
- Kvedaraite, E., & Ginhoux, F.
- Venue
- Science Immunology
- Published
- 2022-04-15
- Volume
- 7
- Issue
- 70
- Pages
- eabm9409-eabm9409
- ISSN
- 2470-9468 (ISSN-L)
- OpenAlex
- W4220979904
- Cited by
- 257
- References
- 95
- FWCI
- 15.37
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.